Predicting human hepatic clearance using hypernet neural networks

19th International Conference on Software Engineering and Data Engineering 2010, SEDE 2010

Volumn , Issue , 2010, Pages 355-359

  Sheikh Bahaei, Shahab ^a   Ali, Kamran A ^b   Bera, Sabina R ^c   Hunt, C Anthony ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURATE PREDICTION; COMPLEX NATURE; FEATURE SPACE; HUMAN LIVER; PHYSICOCHEMICAL PROPERTY; PREDICTION PERFORMANCE; QUADRATIC DISCRIMINANTS; SIMPLE LEARNING ALGORITHMS;

FORECASTING; NEURAL NETWORKS;

SOFTWARE ENGINEERING;

EID: 79953887472     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (19)

1. J. DiMasi, R. Hansen, H. Grabowski, "The price of innovation: new estimates of drug development costs" J Health Econ, Vol. 22(2), pp. 151-85, 2003.
2. D. Hinz, "Process analytical technologies in the pharmaceutical industry: the FDA's PAT initiative" Anal Bioanal Chem, Vol. 384, pp. 1036-1042, 2006.
3. J. Augen, "The evolving role of information technology in the drug discovery process" Drug Discovery Today, Vol. 7, no. 5, pp. 315-23. 2002.
4. P. Rajasethupathy, S.J. Vayttaden and U.S. Bhalla, "Systems modeling: a pathway to drug discovery" Current Opinion in Chemical Biology, Vol. 9, no. 4, pp. 400-406, 2005.
5. D.L. Hudson and M.E. Cohen, Neural Networks and Artificial Intelligence for Biomedical Engineering, IEEE Press, New York, 1999.
6. PubChem database, National Center for Biotechnology Information, available via http://pubchem.ncbi.nlm.nih.gov/
7. Marvin 4.1.7, 2007, ChemAxon, available via http://www.chemaxon.com
8. J.J.P. Stewart, "MOPAC, A Semi-Empirical Molecular Orbital Program" QCPE, pp. 455, 1983.
9. MOPAC2007, 2007, James Stewart, http://openmopac.net/
10. D.F. McGinnity, M.G. Soars, R.A. Urbanowicz, and R.J. Riley, "Evaluation of Fresh and Cryopreserved Hepatocytes as In Vitro Drug Metabolism Tools for the Prediction of Metabolic Clearance" Drug Metabolism And Disposition, Vol. 32, no. 11, pp. 1247-53, 2004.
11. Y.Y. Lau, E. Sapidou, X. Cui, R.E. White, K.C. Cheng, "Development of a novel in vitro model to predict hepatic clearance using fresh, cryopreserved, and sandwich-cultured hepatocytes." Drug Metab Dispos, Vol. 30(12), pp. 1446-54, 2002.
12. G. Schneider, P. Coassolo, T. Lavé, "Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques" J Med Chem, Vol. 42(25), pp. 5072-6, 1999.
13. S. Lee, D. Kim, "A new method for predicting human hepatic clearance from in vitro experimental data using molecular descriptors" Arch Pharm Res, Vol. 30(2):182-90, 2007.
14. J.B. Houston, "Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance" Biochem Pharmacol, Vol. 47(9), pp. 1469-79, 1994.
15. J.B. Houston, D.J. Carlile, "Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices" Drug Metab Rev, Vol. 29(4), pp. 891-922, 1997.
16. T. Lave, S. Dupin, C. Schmitt, R.C. Chou, D. Jaeck, P. Coassolo, "Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs" J Pharm Sci, Vol. 86(5), pp. 584-90, 1997.
17. J. Zuegge, G. Schneider, P. Coassolo, T. Lavé, "Prediction of hepatic metabolic clearance: comparison and assessment of prediction models" Clin Pharmacokinet, Vol. 40(7), pp. 553-63, 2001.
18. K. Ito, J.B. Houston, "Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes" Pharm Res, Vol. 21(5), pp. 785-92, 2004.
19. C. A. Hunt, G. E. Ropella, T. N. Lam, J. Tang, S. H. Kim, J. A. Engelberg, S. Sheikh-Bahaei, "At the biological modeling and simulation frontier" Pharm Res, Vol. 26(11), pp. 2369-400, 2009.